Non-Executive Director of Applied Science Inc., and Key Biologics LLC. (supplier of cells for research and clinical use)

Advises organizations developing medical devices for cell/gene manufacturing and blood banking applications

Member of the AABB Public Policy Strategic Steering Committee

Retired from Terumo BCT in 2015 after 28 years

• Lead business teams developing novel medical devices that served critical patient needs in blood banking, cell therapy and therapeutic apheresis. Cell Therapy platforms included cell collection, processing, expansion, washing and storage systems

• Drove commercialization strategies to achieve market leading positions.  Key customer targets included; Academic centers, Biotechs and CMOs

• Instrumental in coordinating associative functions including scientific, clinical, regulatory and technical

• While based in Hong Kong, lead the commercial efforts in Asia for 6 years

• Championed various executive positions responsible for global business units and strategy development

Developed a global clinical network in Hematology, Immunology and Transfusion Medicine

2 Public – Private partnerships. Non-executive director of TransBio, focused on biomarker innovation for inflammatory diseases and cancer. Helped another group raise $25 M to develop a cell therapy manufacturing. Advised this group whose focus was innovating novel biomaterials and their manufacturing process integration